Clients are responsible for all fees incurred for tests performed at UAGC-CS. Individuals should check with their insurance company prior to testing to understand what services may be covered. Inquiries regarding UAGC-CS billing policies can be made to: Attn: Gina Delgado UAGC-CS Clinical Services Coordinator
Thomas W Keating Building 1657 E. Helen Street Tucson, Arizona 85721 Phone: (520) 626-5002 Fax: (520) 626-7701
Specimen Collection Instructions
All samples must have three patient identifiers: Patient Name (e.g. last name, first initial), Date, Medical Record or other identifier. Each sample must be accompanied by a completed Requisition form and confirmation of a signed Patient Consent form. NOTE: Improperly labeled specimens will be rejected.
The following are the minimum specimen packaging guidelines that should be followed when submitting specimens.
- Ensure that all specimen container caps and lids are properly tightened to prevent leakage.
- Properly complete the requisition.
- Collect the specimen(s) and transfer to a proper transport container, if needed.
- Double check the specimen container to ensure that the device is not beyond its stated expiration date.
Delivery address: University of Arizona Genetics Core – Clinical Services Laboratory 1657 E. Helen Street Keating Building room 111H Tucson, Arizona 85721 520 626-5002 Clinical samples arriving in the UAGC for testing must have at least the following 3 different identifiers in addition to the hospital assigned unique barcode:
- Patient Name (e.g. last name, first initial)
- Medical Record or other identifier
Monday to Friday, 09:00 – 17:00 (Routine Service) Closed Weekends and Public Holidays (see University Closure schedule)
Ship samples overnight at room temperature, Monday-Thursday only. Blood samples will only be accepted if they arrive within 96 hours after collection.
infectious material shipping
In 2006, the U.S. Department of Transportation (DOT) changed the rules for classifying specimens for transport, consistent with the International Air Transport Association (IATA) rules that had previously been changed. Under the new rules most specimens for clinical testing may be classified as either “Exempt” specimens or “Biological Substance, Category B–UN3373” specimens, however classifying and packaging routine specimens for testing as Biological Substance, Category B ensures that appropriate packaging and precautions are taken. Only certain specimens with a higher potential to transmit severe, disabling or fatal diseases must be declared and packaged as “Infectious Substance, Category A–UN2814”. (The DOT regulations can be found at 49CFR173.134 et seq. The 2006 amendments to these regulations can be found at 71FR32258). Those needing to transport infectious substances should check with the DOT, the U.S. Centers for Disease Control (CDC) or public health authorities to determine classification of the specimen and, correspondingly, how the specimen should be packaged for transport. For example, certain cultures must be packaged as a DOT or IATA “infectious substance.” In addition, some air carriers may not consider certain specimens as suitable for air transport. Individuals that ship infectious, potentially infectious, or regulated plant material with commercial carriers (i.e. FedEx, UPS, etc.) are required to have the proper training. This is mandated by the U.S. Department of Transportation and/or the International Air Transport Association. The UAGC is certified to handle BSL2 agents. Infectious substances requiring a higher level of control should not be sent to the UAGC. Please contact the UAGC for additional information.